Recent treatments of interstitial lung disease with systemic sclerosis

Hidekata Yasuoka

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Systemic sclerosis (SSc) is a disorder characterized by immune dysfunction, microvascular injury, and fibrosis. Organ involvement in patients with SSc is variable; however, pulmonary involvement occurs in up to 90% of patients with SSc. Interstitial lung disease (ILD) is a major cause of mortality and, thus, a major determinant in the prognosis of patients with SSc. This review summarizes current findings about the characteristics of ILD in patients with SSc, selection of patients with SSc-ILD who are candidates for the treatment, and current treatment options.

Original languageEnglish
Pages (from-to)97-110
Number of pages14
JournalClinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine
Volume9
DOIs
Publication statusPublished - 2016 Jan 19

Fingerprint

Systemic Scleroderma
Interstitial Lung Diseases
Therapeutics
Immune System Diseases
Patient Selection
Fibrosis
Lung
Mortality
Wounds and Injuries

Keywords

  • Interstitial lung disease
  • Pulmonary hypertension
  • Systemic sclerosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine

Cite this

Recent treatments of interstitial lung disease with systemic sclerosis. / Yasuoka, Hidekata.

In: Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol. 9, 19.01.2016, p. 97-110.

Research output: Contribution to journalArticle

@article{c4f94bb8aba64df58b64b320f4c85542,
title = "Recent treatments of interstitial lung disease with systemic sclerosis",
abstract = "Systemic sclerosis (SSc) is a disorder characterized by immune dysfunction, microvascular injury, and fibrosis. Organ involvement in patients with SSc is variable; however, pulmonary involvement occurs in up to 90{\%} of patients with SSc. Interstitial lung disease (ILD) is a major cause of mortality and, thus, a major determinant in the prognosis of patients with SSc. This review summarizes current findings about the characteristics of ILD in patients with SSc, selection of patients with SSc-ILD who are candidates for the treatment, and current treatment options.",
keywords = "Interstitial lung disease, Pulmonary hypertension, Systemic sclerosis",
author = "Hidekata Yasuoka",
year = "2016",
month = "1",
day = "19",
doi = "10.4137/CCRPM.S23315",
language = "English",
volume = "9",
pages = "97--110",
journal = "Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine",
issn = "1179-5484",
publisher = "Libertas Academica Ltd.",

}

TY - JOUR

T1 - Recent treatments of interstitial lung disease with systemic sclerosis

AU - Yasuoka, Hidekata

PY - 2016/1/19

Y1 - 2016/1/19

N2 - Systemic sclerosis (SSc) is a disorder characterized by immune dysfunction, microvascular injury, and fibrosis. Organ involvement in patients with SSc is variable; however, pulmonary involvement occurs in up to 90% of patients with SSc. Interstitial lung disease (ILD) is a major cause of mortality and, thus, a major determinant in the prognosis of patients with SSc. This review summarizes current findings about the characteristics of ILD in patients with SSc, selection of patients with SSc-ILD who are candidates for the treatment, and current treatment options.

AB - Systemic sclerosis (SSc) is a disorder characterized by immune dysfunction, microvascular injury, and fibrosis. Organ involvement in patients with SSc is variable; however, pulmonary involvement occurs in up to 90% of patients with SSc. Interstitial lung disease (ILD) is a major cause of mortality and, thus, a major determinant in the prognosis of patients with SSc. This review summarizes current findings about the characteristics of ILD in patients with SSc, selection of patients with SSc-ILD who are candidates for the treatment, and current treatment options.

KW - Interstitial lung disease

KW - Pulmonary hypertension

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84960345465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960345465&partnerID=8YFLogxK

U2 - 10.4137/CCRPM.S23315

DO - 10.4137/CCRPM.S23315

M3 - Article

AN - SCOPUS:84960345465

VL - 9

SP - 97

EP - 110

JO - Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

JF - Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

SN - 1179-5484

ER -